Latest News
Natera acquires Foresight Diagnostics to expand MRD capabilities
5 December 2025 - Cell-free DNA testing company Natera Inc (NASDAQ:NTRA) announced on Friday that it has acquired Foresight Diagnostics, a leader in ultrasensitive molecular residual disease (MRD) detection for cancer.The all-stock transaction includ...
Galderma secures EU MDR certification for Sculptra, expanding use to multiple body areas
5 December 2025 - Dermatology specialist Galderma (SWX:GALD) announced on Friday that its regenerative biostimulator Sculptra has received EU Medical Device Regulation (MDR) certification, extending its use beyond facial applications to the gluteal a...
FDA clears Bristol Myers Squibb's Breyanzi as first CAR T therapy for relapsed or refractory marginal zone lymphoma
5 December 2025 - Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) announced late Thursday that it has received US Food and Drug Administration (FDA) approval for Breyanzi (lisocabtagene maraleucel; liso-cel), a CD19-directed CAR T cell ther...
J & D Pharmaceuticals' investigational therapy for HCC receives US FDA Orphan Drug Designation
5 December 2025 - Biopharmaceutical company J & D Pharmaceuticals LLC announced on Thursday that it has received Orphan Drug Designation from the US Food and Drug Administration (FDA) for its investigational therapy for the treatment of Hepatocel...
OncoHost named Gold Winner in 2025 Merit Awards for Healthcare
5 December 2025 - OncoHost, a technology company focused on transforming the approach to precision oncology through proteomics and AI, announced on Thursday that it has been honoured as a Gold Winner in the 2025 Merit Awards for Healthcare, with reco...